|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-D-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11)
Medical Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Abstract
We previously determined that expression of human multidrug resistance protein (MRP) 8, a recently described member of the MRP family of ATP-binding cassette transporters, enhances cellular extrusion of cyclic nucleotides and confers resistance to nucleotide analogs (J Biol Chem 278:2950929514, 2003). However, the in vitro transport characteristics of the pump have not been determined. In this study, the substrate selectivity and biochemical activity of MRP8 is investigated using membrane vesicles prepared from LLC-PK1 cells transfected with MRP8 expression vector. Expression of MRP8 is shown to stimulate the ATP-dependent uptake of a range of physiological and synthetic lipophilic anions, including the glutathione S-conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-sulfate, glucuronides such as estradiol 17-
-D-glucuronide (E217
G), the monoanionic bile acids glycocholate and taurocholate, and methotrexate. In addition, MRP8 is competent in the in vitro transport of cAMP and cGMP, in accord with the results of our previously reported cellular studies. DHEAS, E217
G, and methotrexate were transported with Km and Vmax values of 13.0 ± 0.8 µM and 34.9 ± 9.5 pmol/mg/min, 62.9 ± 12 µM and 62.0 ± 5.2 pmol/mg/min, and 957 ± 28 µM and 317 ± 17 pmol/mg/min, respectively. Based upon the stimulatory action of DHEAS on uptake of E217
G, the attenuation of this effect at high DHEAS concentrations and the lack of reciprocal promotion of DHEAS uptake by E217
G, a model involving nonreciprocal constructive interactions between some transport substrates is invoked. These results suggest that MRP8 participates in physiological processes involving bile acids, conjugated steroids, and cyclic nucleotides and indicate that the pump has complex interactions with its substrates.
Address correspondence to: Dr. Gary D. Kruh, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111. E-mail: gd_kruh{at}fccc.edu.
This article has been cited by other articles:
![]() |
Y. Toyoda, A. Sakurai, Y. Mitani, M. Nakashima, K.-i. Yoshiura, H. Nakagawa, Y. Sakai, I. Ota, A. Lezhava, Y. Hayashizaki, et al. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J, June 1, 2009; 23(6): 2001 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, K. Kock, C. A. Ritter, Z.-S. Chen, M. Grube, G. Jedlitschky, T. Illmer, M. Ayres, J. F. Beck, W. Siegmund, et al. Expression of ABCC-Type Nucleotide Exporters in Blasts of Adult Acute Myeloid Leukemia: Relation to Long-term Survival Clin. Cancer Res., March 1, 2009; 15(5): 1762 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishimura, Y. Seki, K. Sato, T. Chishu, N. Kose, T. Terasaki, Y.-S. Kang, Y. Sai, and E. Nakashima Enhancement of Zidovudine Uptake by Dehydroepiandrosterone Sulfate in Rat Syncytiotrophoblast Cell Line TR-TBT 18d-1 Drug Metab. Dispos., October 1, 2008; 36(10): 2080 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Honorat, A. Mesnier, J. Vendrell, J. Guitton, I. Bieche, R. Lidereau, G. D Kruh, C. Dumontet, P. Cohen, and L. Payen ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor {alpha} expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells Endocr. Relat. Cancer, March 1, 2008; 15(1): 125 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. P. Lin, Y.-L. Zhu, D. R. Johnson, K. P. Rice, T. Nottoli, B. C. Hains, J. McGrath, S. G. Waxman, and A. C. Sartorelli Disruption of cAMP and Prostaglandin E2 Transport by Multidrug Resistance Protein 4 Deficiency Alters cAMP-Mediated Signaling and Nociceptive Response Mol. Pharmacol., January 1, 2008; 73(1): 243 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. P. Leite, J. Echevarria-Lima, S. C. Ferreira, J. B. Calixto, and V. M. Rumjanek ABCC transporter inhibition reduces zymosan-induced peritonitis J. Leukoc. Biol., September 1, 2007; 82(3): 630 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oguri, Y. Bessho, H. Achiwa, H. Ozasa, K. Maeno, H. Maeda, S. Sato, and R. Ueda MRP8/ABCC11 directly confers resistance to 5-fluorouracil Mol. Cancer Ther., January 1, 2007; 6(1): 122 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choudhuri and C. D. Klaassen Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters International Journal of Toxicology, July 1, 2006; 25(4): 231 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dallas, D. S. Miller, and R. Bendayan Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161. [Abstract] [Full Text] [PDF] |
||||